☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Ischaemic
AstraZeneca's Brilinta (ticagrelor) Receives the US FDA's Approval to Reduce the Risk of Stroke in Patients with an Acute Ischemic...
November 6, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.